Archive: Jan 2018

Rexgenero treats first patients in CLI trial – PharmaTimes

January 30, 2018

London, UK-based Rexgenero has reached a major milestone in treating the first patient in a late-stage trial with its lead product, cell therapy REX-001. – News – PharmaTimes Source: Rexgenero treats first patients in CLI trial – PharmaTimes

Read More →

5 Years On: The sad truth about diabetic foot disease

January 13, 2018

It has been 5 years since Travis Hayden-Rowe made this beautiful video celebrating 6 of our courageous patients' struggle with diabetic foot disease. 3 of them have passed away since. The diabetic foot is a marker for death but the wound isn't what leads to their demise. They die of heart attacks and strokes. We need to do more to recognize this fact and treat the factors that lead to this end. The presentation of the diabetic foot should not be just…

Read More →